Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 13/20 | 1.00 |
| ▸ | MEN1 | O00255 | 4/20 | 1.00 |
| ▸ | GMNN | O75496 | 4/20 | 1.00 |
| ▸ | LMNA | P02545 | 4/20 | 1.00 |
| ▸ | POLB | P06746 | 4/20 | 1.00 |
| ▸ | MAPT | P10636 | 4/20 | 1.00 |
| ▸ | APEX1 | P27695 | 4/20 | 1.00 |
| ▸ | RECQL | P46063 | 4/20 | 1.00 |
| ▸ | BLM | P54132 | 4/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 4/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 4/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | TP53 | P04637 | 3/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 3/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 2/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6299633 | 1.00 | PRKCA (1.00) | PRKCAMEN1GMNNLMNAPOLB | |
| SCHEMBL6305111 | 1.00 | PRKCA (1.00) | PRKCAMEN1GMNNLMNAPOLB | |
| Dequalinium SCHEMBL29577841 | 1.00 | PRKCA (1.00) | PRKCAMEN1GMNNLMNAPOLB | |
| SCHEMBL6298118 | 1.00 | PRKCA (1.00) | PRKCAMEN1GMNNLMNAPOLB | |
| Dequalinium SCHEMBL29557297 | 1.00 | PRKCA (1.00) | PRKCAMEN1GMNNLMNAPOLB | |
| Dequalinium SCHEMBL2335922 | 0.98 | PRKCA (1.00) | PRKCAMEN1GMNNLMNAPOLB | |
| Dequalinium SCHEMBL2544854 | 0.98 | MEN1 (1.00) | PRKCAMEN1GMNNLMNAPOLB | |
| Dequalinium SCHEMBL1008339 | 0.98 | PRKCA (0.97) | PRKCAMEN1GMNNLMNAPOLB | |
| Dequalinium SCHEMBL29613054 | 0.98 | MEN1 (1.00) | PRKCAMEN1GMNNLMNAPOLB | |
| Dequalinium SCHEMBL34043 | 0.98 | MEN1 (1.00) | PRKCAMEN1GMNNLMNAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1276 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250352653-A1 | NEURON TARGETED 2-DEOXYGLUCOSE DENDRIMER FOR IMAGING AND TREATMENT OF NEUROLOGICAL DISEASES | UNIV WASHINGTON STATE (US) | 2025-11-20 | — | — | US | claimed |
| US-20250271426-A1 | REDUCTION OF BITTER TASTE OF ACTIVE PHARMACEUTICAL INGREDIENTS AND RELATED ASSAYS AND SCREENING METHODS | FIRMENICH INCORPORATED (US) | 2025-08-28 | — | — | US | claimed |
| WO-2025137193-A1 | BFL-1 INHIBITORS | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2025-06-26 | — | — | WO | claimed |
| US-20250177373-A1 | COMPOSITIONS AND METHODS FOR TARGETING A VIRAL INFECTION | THE CHILDEREN'S MEDICAL CENTER CORPORATION (US) | 2025-06-05 | — | — | US | claimed |
| US-20250163388-A1 | METHODS FOR DERIVATION AND PROPAGATION OF AVIAN PLURIPOTENT STEM CELLS AND APPLICATIONS THEREOF | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2025-05-22 | — | — | US | claimed |
| US-20250144078-A1 | THIOSTREPTON-INSPIRED COMPOUNDS FOR TREATMENT OF CANCER AND PREPARATION THEREOF | SYMERES NETHERLANDS B.V. (NL) | 2025-05-08 | — | — | US | claimed |
| US-12274830-B2 | Nitric oxide inhalation therapy for infants with bronchiolitis | BEYOND AIR LTD (IL) | 2025-04-15 | — | — | US | claimed |
| WO-2025058566-A1 | ORALLY-DELIVERED PLATINUM PRO-DRUG AGAINST CISPLATIN-RESISTANT OVARIAN CANCER | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2025-03-20 | — | — | WO | claimed |
| US-12247246-B2 | Identification of inhibitors of TcpC and TIR NADase activity | WASHINGTON UNIVERSITY (US) | 2025-03-11 | — | — | US | claimed |
| EP-4493928-A1 | REDUCTION OF BITTER TASTE OF ACTIVE PHARMACEUTICAL INGREDIENTS AND RELATED ASSAYS AND SCREENING METHODS | Firmenich Incorporated (US) | 2025-01-22 | — | — | EP | claimed |
| WO-1999013096-A1 | MATERIALS AND METHODS FOR INTRACELLULAR DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES | UNIVERSITY OF FLORIDA (US) | 1999-03-18 | — | — | WO | claimed |
| EP-0783292-A1 | INHIBITION OF HAIR GROWTH | HANDELMAN, Joseph H. (US) | 1997-07-16 | — | — | EP | claimed |
| US-5554608-A | INHIBITOR OF PROTEIN KINASE C | GILLETTE COMPANY, THE, A DELAWARE CORPORATION | 1996-09-10 | — | — | US | claimed |
| WO-1996009806-A2 | INHIBITION OF HAIR GROWTH | HANDELMAN, JOSEPH, H. (US) | 1996-04-04 | — | — | WO | claimed |
| EP-0617611-B1 | ORAL OSMOTIC DEVICE | ALZA CORP (US) | 1996-01-31 | — | — | EP | claimed |
| EP-0399479-B1 | CHEWING GUM FOR THE DISINFECTION OF THE MOUTH AND THE THROAT AND PROCESS FOR ITS PREPARATION | Gergely, Gerhard, Dr. (AT) | 1993-08-11 | — | — | EP | claimed |
| US-4946849-A | Method for the treatment of malaria | FLOW INCORPORATED (US) | 1990-08-07 | — | — | US | claimed |
| EP-0148242-A4 | METHOD AND APPARATUS FOR TREATING AILMENTS. | KRAUSER ROBERT S | 1987-06-03 | — | — | EP | claimed |
| EP-0148242-A1 | METHOD AND APPARATUS FOR TREATING AILMENTS. | KRAUSER ROBERT S | 1985-07-17 | — | — | EP | claimed |
| WO-1985000112-A1 | METHOD AND APPARATUS FOR TREATING AILMENTS | KRAUSER ROBERT S | 1985-01-17 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12247246-B2 | Identification of inhibitors of TcpC and TIR NADase activity | NADK, NAPRT, TIPARP | PRKCA 2174/4885MEN1 3678/4885GMNN 2521/4885 |
| US-20250177373-A1 | COMPOSITIONS AND METHODS FOR TARGETING A VIRAL INFECTION | HAVCR2, CD4, MAVS | PRKCA 1569/4885MEN1 3851/4885GMNN 1645/4885 |
| US-20250144078-A1 | THIOSTREPTON-INSPIRED COMPOUNDS FOR TREATMENT OF CANCER AND PREPARATION THEREOF | TYMS, TOP1, TOP2A | PRKCA 2656/4885MEN1 2742/4885GMNN 257/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.